-
1
-
-
84876719548
-
Sexually transmitted infections among HIV-infected women in Thailand
-
Asavapiriyanont S, Lolekha R, Roongpisuthipong A, Wiratchai A, Kaoiean S, Suksripanich O, Chalermchockcharoenkit A, Ausavapipit J, Srifeungfung S, Pattanasin S et al. Sexually transmitted infections among HIV-infected women in Thailand. BMC Public Health 2013;13:373.
-
(2013)
BMC Public Health
, vol.13
, pp. 373
-
-
Asavapiriyanont, S.1
Lolekha, R.2
Roongpisuthipong, A.3
Wiratchai, A.4
Kaoiean, S.5
Suksripanich, O.6
Chalermchockcharoenkit, A.7
Ausavapipit, J.8
Srifeungfung, S.9
Pattanasin, S.10
-
4
-
-
1642368576
-
-
Washington, DC, USA: Population Reference Bureau
-
Clifton D, Kaneda T, Ashford L. Family PlanningWorldwide, 2008 Data Sheet. Washington, DC, USA: Population Reference Bureau.
-
Family PlanningWorldwide, 2008 Data Sheet
-
-
Clifton, D.1
Kaneda, T.2
Ashford, L.3
-
5
-
-
0026520859
-
Intrauterine devices and pelvic inflammatory disease: An international perspective
-
Farley TM, Rosenberg MJ, Rowe PJ, Chen JH, Meirik O. Intrauterine devices and pelvic inflammatory disease: an international perspective. Lancet 1992; 339:785-788.
-
(1992)
Lancet
, vol.339
, pp. 785-788
-
-
Farley, T.M.1
Rosenberg, M.J.2
Rowe, P.J.3
Chen, J.H.4
Meirik, O.5
-
6
-
-
0003638576
-
Progestogenreleasing intrauterine systems versus other forms of reversible contraceptives for contraception
-
French R, Sorhaindo AM, Van Vliet HAAM, Mansour DD, Robinson AA, Logan S, Helmerhorst FM, Guillebaud J, Cowan FM. Progestogenreleasing intrauterine systems versus other forms of reversible contraceptives for contraception. Cochrane Database Syst Rev 2004; doi:10. 1002/14651858. CD001776. pub2.
-
(2004)
Cochrane Database Syst Rev
-
-
French, R.1
Sorhaindo, A.M.2
Van Vliet, H.A.A.M.3
Mansour, D.D.4
Robinson, A.A.5
Logan, S.6
Helmerhorst, F.M.7
Guillebaud, J.8
Cowan, F.M.9
-
7
-
-
0034675262
-
Intrauterine device and upper-genital-tract infection
-
Grimes DA. Intrauterine device and upper-genital-tract infection. Lancet 2000;356:1013-1019.
-
(2000)
Lancet
, vol.356
, pp. 1013-1019
-
-
Grimes, D.A.1
-
8
-
-
0035235287
-
Antibiotic prophylaxis for intrauterine contraceptive device insertion
-
Grimes DA, Lopez LM, Schulz KF. Antibiotic prophylaxis for intrauterine contraceptive device insertion. Cochrane Database Syst Rev 1999. doi:10. 1002/14651858. CD001327.
-
(1999)
Cochrane Database Syst Rev
-
-
Grimes, D.A.1
Lopez, L.M.2
Schulz, K.F.3
-
9
-
-
0022981955
-
Predicting acute pelvic inflammatory disease: A multivariate analysis
-
Hadgu A, Westrom L, Brooks CA, Reynolds GH, Thompson SE. Predicting acute pelvic inflammatory disease: a multivariate analysis. Am J Obstet Gynecol 1998;155:954-960.
-
(1998)
Am J Obstet Gynecol
, vol.155
, pp. 954-960
-
-
Hadgu, A.1
Westrom, L.2
Brooks, C.A.3
Reynolds, G.H.4
Thompson, S.E.5
-
10
-
-
33750012689
-
The levonorgestrel-releasing intrauterine system (LNG-IUS) in HIV-infected women-effects on bleeding patterns, ovarian function and genital shedding of HIV
-
Heikinheimo O, Lehtovirta P, Suni J, Paavonen J. The levonorgestrel-releasing intrauterine system (LNG-IUS) in HIV-infected women-effects on bleeding patterns, ovarian function and genital shedding of HIV. Hum Reprod 2006;21:2857-2861.
-
(2006)
Hum Reprod
, vol.21
, pp. 2857-2861
-
-
Heikinheimo, O.1
Lehtovirta, P.2
Suni, J.3
Paavonen, J.4
-
11
-
-
0014626656
-
Objectivized diagnosis of acute pelvic inflammatory disease. Diagnostic and prognostic value of routine laparoscopy
-
Jacobson L, Westrom L. Objectivized diagnosis of acute pelvic inflammatory disease. Diagnostic and prognostic value of routine laparoscopy. Am J Obstet Gynecol 1969;105:1088-1098.
-
(1969)
Am J Obstet Gynecol
, vol.105
, pp. 1088-1098
-
-
Jacobson, L.1
Westrom, L.2
-
12
-
-
44949137340
-
Copper containing, framed intrauterine devices for contraception
-
Kulier R, O'Brien P, HelmerhorstFM, Usher-Patel M, d'Arcangues C. Copper containing, framed intrauterine devices for contraception. Cochrane Database Syst Rev 2007. doi:10. 1002/14651858. CD005347. pub3.
-
(2007)
Cochrane Database Syst Rev
-
-
Kulier, R.1
O'brien, P.2
Helmerhorst, F.M.3
Usher-Patel, M.4
D'arcangues, C.5
-
13
-
-
0023239642
-
Effective contraception with the levonorgestrel-releasing intrauterine device: 12-month report of a European multicenter study
-
Luukkainen T, Allonen H, Haukkamaa M, Holma P, Pyorala T, Terho J, Toivonen J, Batar I, Lampe L, Andersson K et al. Effective contraception with the levonorgestrel-releasing intrauterine device: 12-month report of a European multicenter study. Contraception 1987;36:169-179.
-
(1987)
Contraception
, vol.36
, pp. 169-179
-
-
Luukkainen, T.1
Allonen, H.2
Haukkamaa, M.3
Holma, P.4
Pyorala, T.5
Terho, J.6
Toivonen, J.7
Batar, I.8
Lampe, L.9
Andersson, K.10
-
15
-
-
19444370313
-
Keeping up with evidence a new system forWHO's evidence-based family planning guidance
-
MohllajeeAP, CurtisKM, FlanaganRG, RinehartW, GaffieldML, PetersonHB. Keeping up with evidence a new system forWHO's evidence-based family planning guidance. Am J Prev Med 2005;28:483-490.
-
(2005)
Am J Prev Med
, vol.28
, pp. 483-490
-
-
Mohllajee, A.P.1
Curtis, K.M.2
Flanagan, R.G.3
Rinehart, W.4
Gaffield, M.L.5
Peterson, H.B.6
-
16
-
-
30644456797
-
Does insertion and use of an intrauterine device increase the risk of pelvic inflammatory disease among women with sexually transmitted infection A systematic review
-
Mohllajee AP, Curtis KM, Peterson HB. Does insertion and use of an intrauterine device increase the risk of pelvic inflammatory disease among women with sexually transmitted infection A systematic review. Contraception 2006;73:145-153.
-
(2006)
Contraception
, vol.73
, pp. 145-153
-
-
Mohllajee, A.P.1
Curtis, K.M.2
Peterson, H.B.3
-
17
-
-
0034928887
-
Is the intrauterine device appropriate contraception for HIV-1-infected women
-
Morrison CS, Sekadde-Kigondu C, Sinei SK, Weiner DH, Kwok C, Kokonya D. Is the intrauterine device appropriate contraception for HIV-1-infected women. BJOG 2001;108:784-790.
-
(2001)
BJOG
, vol.108
, pp. 784-790
-
-
Morrison, C.S.1
Sekadde-Kigondu, C.2
Sinei, S.K.3
Weiner, D.H.4
Kwok, C.5
Kokonya, D.6
-
18
-
-
79955534404
-
Continuation and satisfaction of reversible contraception
-
Peipert JF, Zhao Q, Allsworth JE, Petrosky E, Madden T, Eisenberg D, Secura G. Continuation and satisfaction of reversible contraception. Obstet Gynecol 2011;117:1105-1113.
-
(2011)
Obstet Gynecol
, vol.117
, pp. 1105-1113
-
-
Peipert, J.F.1
Zhao, Q.2
Allsworth, J.E.3
Petrosky, E.4
Madden, T.5
Eisenberg, D.6
Secura, G.7
-
19
-
-
77950189829
-
CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials
-
Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. Br Med J 2010; 340:c332.
-
(2010)
Br Med J
, vol.340
, pp. c332
-
-
Schulz, K.F.1
Altman, D.G.2
Moher, D.3
-
20
-
-
27144511739
-
A comparative study of the levonorgestrel-releasing intrauterine system Mirena versus the Copper T380A intrauterine device during lactation: Breast-feeding performance, infant growth and infant development
-
Shaamash AH, Sayed GH, Hussien MM, Shaaban MM. A comparative study of the levonorgestrel-releasing intrauterine system Mirena versus the Copper T380A intrauterine device during lactation: breast-feeding performance, infant growth and infant development. Contraception 2005; 72:346-351.
-
(2005)
Contraception
, vol.72
, pp. 346-351
-
-
Shaamash, A.H.1
Sayed, G.H.2
Hussien, M.M.3
Shaaban, M.M.4
-
21
-
-
0035835432
-
Risk of clinical pelvic inflammatory disease attributable to an intrauterine device
-
Shelton JD. Risk of clinical pelvic inflammatory disease attributable to an intrauterine device. Lancet 2001;357:443.
-
(2001)
Lancet
, vol.357
, pp. 443
-
-
Shelton, J.D.1
-
22
-
-
0025365428
-
Preventing IUCD-related pelvic infection: The efficacy of prophylactic doxycycline at insertion
-
Sinei SK, Schulz KF, Lamptey PR, Grimes DA, Mati JK, Rosenthal SM, Rosenberg MJ, Riara G, Njage PN, Bhullar VB. Preventing IUCD-related pelvic infection: the efficacy of prophylactic doxycycline at insertion. Br J Obstet Gynaecol 1990;97:412-419.
-
(1990)
Br J Obstet Gynaecol
, vol.97
, pp. 412-419
-
-
Sinei, S.K.1
Schulz, K.F.2
Lamptey, P.R.3
Grimes, D.A.4
Mati, J.K.5
Rosenthal, S.M.6
Rosenberg, M.J.7
Riara, G.8
Njage, P.N.9
Bhullar, V.B.10
-
23
-
-
0032565332
-
Complications of use of intrauterine devices among HIV-1-infected women
-
Sinei SK, Morrison CS, Sekadde-Kigondu C, Allen M, Kokonya D. Complications of use of intrauterine devices among HIV-1-infected women. Lancet 1998;351:1238-1241.
-
(1998)
Lancet
, vol.351
, pp. 1238-1241
-
-
Sinei, S.K.1
Morrison, C.S.2
Sekadde-Kigondu, C.3
Allen, M.4
Kokonya, D.5
-
24
-
-
2442464794
-
Intrauterine contraceptive devices and risk of pelvic inflammatory disease: Standard of care in high STI prevalence settings
-
Steen R, Shapiro K. Intrauterine contraceptive devices and risk of pelvic inflammatory disease: standard of care in high STI prevalence settings. Reprod Health Matters 2004;12:136-143.
-
(2004)
Reprod Health Matters
, vol.12
, pp. 136-143
-
-
Steen, R.1
Shapiro, K.2
-
25
-
-
3342894947
-
Contraceptive failure in the United States
-
Trussell J. Contraceptive failure in the United States. Contraception 2004; 70:89-96.
-
(2004)
Contraception
, vol.70
, pp. 89-96
-
-
Trussell, J.1
-
26
-
-
56549106425
-
Cost effectiveness of contraceptives in the United States
-
Trussell J, Lalla AM, DoanQV, Reyes E, Pinto L, Gricar J. Cost effectiveness of contraceptives in the United States. Contraception 2009;79:5-14.
-
(2009)
Contraception
, vol.79
, pp. 5-14
-
-
Trussell, J.1
Lalla, A.M.2
Doan, Q.V.3
Reyes, E.4
Pinto, L.5
Gricar, J.6
-
27
-
-
84876386689
-
Drug interactions between antiretrovirals and hormonal contraceptives
-
Tseng A, Hills-Nieminen C. Drug interactions between antiretrovirals and hormonal contraceptives. Expert Opin Drug Metab Toxicol 2013; 9:559-572.
-
(2013)
Expert Opin Drug Metab Toxicol
, vol.9
, pp. 559-572
-
-
Tseng, A.1
Hills-Nieminen, C.2
-
28
-
-
84878880014
-
-
Uganda Bureau of Statistics (UBOS) and ICF International Inc. Kampala, Uganda: UBOS and Claverton, Maryland: ICF International Inc. (24 November 2014, date last accessed)
-
Uganda Bureau of Statistics (UBOS) and ICF International Inc. 2012. Uganda Demographic and Health Survey 2011. Kampala, Uganda: UBOS and Claverton, Maryland: ICF International Inc. http://www. ubos. org/ onlinefiles/uploads/ubos/UDHS/UDHS2011. pdf (24 November 2014, date last accessed).
-
(2012)
Uganda Demographic and Health Survey 2011
-
-
-
29
-
-
85026876768
-
-
United Nations, (24 November 2014, date last accessed)
-
United Nations, 2013. Trends in Contraceptive Methods UsedWorldwide http://www. un. org/en/development/desa/population/publications/ pdf/popfacts/PopFacts-2013-9-new. pdf (24 November 2014, date last accessed).
-
(2013)
Trends in Contraceptive Methods UsedWorldwide
-
-
-
30
-
-
79957661127
-
African women recently infected with HIV-1 and HSV-2 have increased risk of acquiring Neisseria gonorrhoeae and Chlamydia trachomatis in the Methods for Improving Reproductive Health in Africa trial
-
Venkatesh KK, van der Straten A, Mayer KH, Blanchard K, Ramjee G, Lurie MN, Chipato T, Padian NS, de Bruyn G. African women recently infected with HIV-1 and HSV-2 have increased risk of acquiring Neisseria gonorrhoeae and Chlamydia trachomatis in the Methods for Improving Reproductive Health in Africa trial. Sex Transm Dis 2011;38:562-570.
-
(2011)
Sex Transm Dis
, vol.38
, pp. 562-570
-
-
Venkatesh, K.K.1
Van Der Straten, A.2
Mayer, K.H.3
Blanchard, K.4
Ramjee, G.5
Lurie, M.N.6
Chipato, T.7
Padian, N.S.8
De Bruyn, G.9
-
31
-
-
0032481859
-
Randomised controlled trial of prophylactic antibiotics before insertion of intrauterine devices
-
Walsh T, Grimes D, Frezieres R, Nelson A, Bernstein L, Coulson A, Bernstein G. Randomised controlled trial of prophylactic antibiotics before insertion of intrauterine devices. IUD Study Group. Lancet 1998; 351:1005-1008.
-
(1998)
IUD Study Group. Lancet
, vol.351
, pp. 1005-1008
-
-
Walsh, T.1
Grimes, D.2
Frezieres, R.3
Nelson, A.4
Bernstein, L.5
Coulson, A.6
Bernstein, G.7
-
32
-
-
77956604422
-
-
World Health Organisation, Geneva: World Health Organization, (24 November 2014, date last accessed), 4th edn
-
World Health Organisation. Medical Eligibility Criteria for Contraceptive Use, 4th edn. Geneva: World Health Organization, 2009. http://whqlibdoc. who. int/publications/2010/9789241563888-eng. pdf (24 November 2014, date last accessed).
-
(2009)
Medical Eligibility Criteria for Contraceptive Use
-
-
|